Fusako Nishigaki
- Molecular Biology
- Rheumatology top 5%
- Oncology
- Organic Chemistry top 10%
- Immunology
- Co-authors
- Toshitaka MandaKyoichi ShimomuraIkuo KawamuraSanae MatsumotoSueo MukumotoY. OhkuboToshio GotoHirotsugu Ueda
- Topics
- Protease and Inhibitor Mechanisms (5 papers)Cancer therapeutics and mechanisms (4 papers)Cancer, Hypoxia, and Metabolism (4 papers)
- Cited by
- ToxicologyRheumatologyBiotechnology
- Partner nations
- JapanUnited States
In The Last Decade
Fusako Nishigaki
40 papers receiving 975 citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 469
- Rheumatology 208
- Oncology 183
- Organic Chemistry 159
- Immunology 141
Countries citing papers authored by Fusako Nishigaki
This map shows the geographic impact of Fusako Nishigaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fusako Nishigaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fusako Nishigaki more than expected).
Fields of papers citing papers by Fusako Nishigaki
This network shows the impact of papers produced by Fusako Nishigaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fusako Nishigaki. The network helps show where Fusako Nishigaki may publish in the future.
Co-authorship network of co-authors of Fusako Nishigaki
This figure shows the co-authorship network connecting the top 25 collaborators of Fusako Nishigaki. A scholar is included among the top collaborators of Fusako Nishigaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fusako Nishigaki. Fusako Nishigaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 12 | |
| 3 | 8 | |
| 4 | 49 | |
| 5 | 32 | |
| 6 | 15 | |
| 7 | 32 | |
| 8 | 40 | |
| 9 | 43 | |
| 10 | 84 | |
| 11 | 6 | |
| 12 | 22 | |
| 13 | 6 | |
| 14 | 16 | |
| 15 | 21 | |
| 16 | 38 | |
| 17 | 2 | |
| 18 | 4 | |
| 19 | 11 | |
| 20 | Antiestrogenic and antitumor effects of droloxifene in experimental breast carcinoma. | 13 |
About Fusako Nishigaki
Fusako Nishigaki is a scholar working on Hematology, Cancer Research and Immunology and Allergy, having authored 41 papers that have together received 1.0k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (5 papers), Cancer therapeutics and mechanisms (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Toxicology (51 citations), Rheumatology (208 citations) and Biotechnology (76 citations). Fusako Nishigaki has collaborated with scholars based in Japan and United States. Frequent co-authors include Toshitaka Manda, Kyoichi Shimomura, Ikuo Kawamura, Sanae Matsumoto, Sueo Mukumoto, Y. Ohkubo, Toshio Goto, Hirotsugu Ueda, Shozo Sakuma and Seitaro Mutoh. Their work appears in journals such as Cancer Research, British Journal of Pharmacology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.